NCT06040541: Study of RMC-9805 in Participants With KRASG12D-Mutant Solid Tumors |
|
|
| Recruiting | 1 | 290 | US | RMC-9805 | Revolution Medicines, Inc. | Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors | 08/25 | 07/26 | | |
